{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:59:16Z","timestamp":1792684756015,"version":"4.5.0"},"reference-count":322,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education in Saudi Arabia","award":["RUP-5"],"award-info":[{"award-number":["RUP-5"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Neurodegenerative disorders (NDs) include Parkinson\u2019s disease (PD), Alzheimer\u2019s disease (AD), Huntington\u2019s disease (HD), and amyotrophic lateral sclerosis (ALS) and the common feature of NDs is the progressive death of specific neurons in the brain. Apoptosis is very important in developing the nervous system, nonetheless an elevated level of cell death has been observed in the case of NDs. NDs are different in terms of their neuronal vulnerability and clinical manifestations, however they have some overlapping neurodegenerative pathways. It has been demonstrated by several studies with cell lines and animal models that apoptosis has a significant contribution to make in advancing AD, ALS, HD, and PD. Numerous dying neurons were also identified in the brains of individuals with NDs and these conditions were found to be linked with substantial cell loss along with common characteristics of apoptosis including activation of caspases and cysteine-proteases, DNA fragmentation, and chromatin condensation. It has been demonstrated that several therapeutic agents including antioxidants, minocycline, GAPDH ligands, p53 inhibitors, JNK (c-Jun N-Terminal Kinase) inhibitors, glycogen synthase kinase-3 inhibitor, non-steroidal anti-inflammatory drugs, D2 dopamine receptor agonists, FK506, cell cycle inhibitors, statins, drugs targeting peroxisome proliferator-activated receptors, and gene therapy have the potential to provide protection to neurons against apoptosis. Therefore, the use of these potential therapeutic agents might be beneficial in the treatment of NDs. In this review, we have summarized the pathways that are linked with apoptotic neuronal death in the case of various NDs. We have particularly focused on the therapeutic agents that have neuroprotective properties and the potential to regulate apoptosis in NDs.<\/jats:p>","DOI":"10.3390\/molecules27217207","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T02:47:26Z","timestamp":1666752446000},"page":"7207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review"],"prefix":"10.3390","volume":"27","author":[{"given":"Hamad Ghaleb","family":"Dailah","sequence":"first","affiliation":[{"name":"Research and Scientific Studies Unit, College of Nursing, Jazan University, Jazan 45142, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnins.2020.00213","article-title":"Neurodegenerative Diseases\u2014Is Metabolic Deficiency the Root Cause?","volume":"14","author":"Muddapu","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Nichols","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfr239","article-title":"The role of environmental exposures in neurodegeneration and neurodegenerative diseases","volume":"124","author":"Cannon","year":"2011","journal-title":"Toxicol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fnins.2019.00728","article-title":"Re-thinking the etiological framework of neurodegeneration","volume":"13","author":"Castillo","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnen\/62.4.340","article-title":"Neurotrophins and Neurodegenerative Diseases: Receptors Stuck in Traffic?","volume":"62","author":"Kruttgen","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI200317522","article-title":"Series Introduction: Neurodegeneration: What is it and where are we?","volume":"111","author":"Przedborski","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: A critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fncel.2019.00066","article-title":"The Impact of Studying Brain Plasticity","volume":"13","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dorszewska, J., Kozubski, W., Waleszczyk, W., Zabel, M., and Ong, K. (2020). Neuroplasticity in the Pathology of Neurodegenerative Diseases. Neural Plast., 2020.","DOI":"10.1155\/2020\/4245821"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12035-012-8302-9","article-title":"Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques","volume":"46","author":"Pilato","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41401-020-0371-0","article-title":"Synaptic and cellular plasticity in Parkinson\u2019s disease","volume":"41","author":"Chu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000005807","article-title":"Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms","volume":"91","author":"Benarroch","year":"2018","journal-title":"Neurology"},{"key":"ref_14","first-page":"376","article-title":"Oxidative stress in neurodegenerative diseases","volume":"7","author":"Chen","year":"2012","journal-title":"Neural Regen. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative stress: A key modulator in neurodegenerative diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidatives stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons. Dis."},{"key":"ref_20","first-page":"5021694","article-title":"Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention","volume":"2020","author":"Montezinho","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.13772","article-title":"Pathogenic mechanisms of prion protein, amyloid-\u03b2 and \u03b1-synuclein misfolding: The prion concept and neurotoxicity of protein oligomers","volume":"139","author":"Ugalde","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: Burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt5","article-title":"Proteinopathy-induced neuronal senescence: A hypothesis for brain failure in Alzheimer\u2019s and other neurodegenerative diseases","volume":"1","author":"Golde","year":"2009","journal-title":"Alzheimers. Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.euroneuro.2013.03.007","article-title":"Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?","volume":"25","author":"Bayer","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4103\/1673-5374.268971","article-title":"Neurodegenerative diseases as proteinopathies-driven immune disorders","volume":"15","author":"Ciccocioppo","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/MMBR.64.4.821-846.2000","article-title":"Proteases for Cell Suicide: Functions and Regulation of Caspases","volume":"64","author":"Chang","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jcb.1186","article-title":"Nuclear apoptotic changes: An overview","volume":"82","author":"Martelli","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1567202043362018","article-title":"Apoptosis: A Key in Neurodegenerative Disorders","volume":"1","author":"Ekshyyan","year":"2004","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: The balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"},{"key":"ref_32","first-page":"455","article-title":"Neuronal cell death in nervous system development, disease, and injury (Review)","volume":"7","author":"Martin","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1747-4949.2012.00839.x","article-title":"Pathophysiologic cascades in ischemic stroke","volume":"7","author":"Xing","year":"2012","journal-title":"Int. J. Stroke"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2020.00051","article-title":"Ischemia-Triggered Glutamate Excitotoxicity from the Perspective of Glial Cells","volume":"14","author":"Kriska","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","article-title":"Apoptosis and Caspases in Neurodegenerative Diseases","volume":"348","author":"Friedlander","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnmol.2018.00101","article-title":"Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury","volume":"11","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/13543784.9.4.747","article-title":"Apoptosis modulators in the therapy of neurodegenerative diseases","volume":"9","author":"Deigner","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17460441.2019.1623784","article-title":"Cell death assays for neurodegenerative disease drug discovery","volume":"14","author":"Linsley","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","article-title":"Regulated cell death: Discovery, features and implications for neurodegenerative diseases","volume":"19","author":"Cui","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1535370219894558","article-title":"Angelica polysaccharide ameliorates memory impairment in Alzheimer\u2019s disease rat through activating BDNF\/TrkB\/CREB pathway","volume":"245","author":"Du","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110954","DOI":"10.1016\/j.exger.2020.110954","article-title":"miR-16-5p is upregulated by amyloid \u03b2 deposition in Alzheimer\u2019s disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2","volume":"136","author":"Kim","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117237","DOI":"10.1016\/j.lfs.2019.117237","article-title":"Antioxidative and antiapoptosis: Neuroprotective effects of dauricine in Alzheimer\u2019s disease models","volume":"243","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13071-020-04164-5","article-title":"Initiator and executioner caspases in salivary gland apoptosis of Rhipicephalus haemaphysaloides","volume":"13","author":"Wang","year":"2020","journal-title":"Parasites Vectors"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer\u2019s disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: Genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuron.2008.07.013","article-title":"Linking Calcium to A\u03b2 and Alzheimer\u2019s Disease","volume":"59","author":"Green","year":"2008","journal-title":"Neuron"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","article-title":"Calcium and neurodegeneration","volume":"6","author":"Mattson","year":"2007","journal-title":"Aging Cell"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Erekat, N.S. (2018). Apoptosis and its Role in Parkinson\u2019s Disease. Park. Dis. Pathog. Clin. Asp., 65\u201382.","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch4"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fnins.2018.00369","article-title":"Neuroprotective effects of proanthocyanidins, natural flavonoids derived from plants, on rotenone-induced oxidative stress and apoptotic cell death in human neuroblastoma SH-SY5Y cells","volume":"12","author":"Ma","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101890","DOI":"10.1016\/j.jchemneu.2020.101890","article-title":"Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson\u2019s disease","volume":"112","author":"Balakrishnan","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.18632\/aging.202181","article-title":"TRIM3 attenuates apoptosis in Parkinson\u2019s disease via activating PI3K\/AKT signal pathway","volume":"13","author":"Dong","year":"2021","journal-title":"Aging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson\u2019s disease","volume":"16","author":"Thomas","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson\u2019s disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1474-4422(07)70246-6","article-title":"Calcium, ageing, and neuronal vulnerability in Parkinson\u2019s disease","volume":"6","author":"Surmeier","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3727\/000000007783464687","article-title":"Huntington\u2019s disease: Pathological mechanisms and therapeutic strategies","volume":"16","author":"Ramaswamy","year":"2007","journal-title":"Cell Transplant."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dot.2007.43.2.1050788","article-title":"Huntington\u2019s disease: Clinical characteristics, pathogenesis and therapies","volume":"43","author":"Nakamura","year":"2007","journal-title":"Drugs Today"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","article-title":"Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington\u2019s disease","volume":"45","author":"Bezprozvanny","year":"2012","journal-title":"Subcell. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.12965\/jer.150212","article-title":"Treadmill exercise enhances spatial learning ability through suppressing hippocampal apoptosis in Huntington\u2019s disease rats","volume":"11","author":"Ji","year":"2015","journal-title":"J. Exerc. Rehabil."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic Lateral Sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.jnen.0000173889.71434.ea","article-title":"The Pathobiology of Amyotrophic Lateral Sclerosis: A Proteinopathy?","volume":"64","author":"Strong","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tins.2005.07.001","article-title":"Ca2+, mitochondria and selective motoneuron vulnerability: Implications for ALS","volume":"28","author":"Keller","year":"2005","journal-title":"Trends Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(01)02250-9","article-title":"Upregulation of the pro-apoptotic BH3-only peptide harakiri in spinal neurons of amyotrophic lateral sclerosis patients","volume":"313","author":"Shinoe","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Patel, B.P., Safdar, A., Raha, S., Tarnopolsky, M.A., and Hamadeh, M.J. (2010). Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009386"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s12035-014-8731-8","article-title":"Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration","volume":"51","author":"Vaz","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.conb.2008.07.013","article-title":"Signaling by death receptors in the nervous system","volume":"18","author":"Haase","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-328X(01)00058-4","article-title":"Caspase mRNA expression in a rat model of focal cerebral ischemia","volume":"89","author":"Harrison","year":"2001","journal-title":"Mol. Brain Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1006\/nbdi.2001.0415","article-title":"Cleavage of Bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures","volume":"8","author":"Henshall","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2006.04.131","article-title":"Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome c-dependent and Smac\/DIABLO-independent way","volume":"1098","author":"Li","year":"2006","journal-title":"Brain Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09857","article-title":"RIP3 mediates the embryonic lethality of caspase-8-deficient mice","volume":"471","author":"Kaiser","year":"2011","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","article-title":"Catalytic activity of the caspase-8-FLIP L complex inhibits RIPK3-dependent necrosis","volume":"471","author":"Oberst","year":"2011","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature09878","article-title":"Functional complementation between FADD and RIP1 in embryos and lymphocytes","volume":"471","author":"Zhang","year":"2011","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Krajewska, M., You, Z., Rong, J., Kress, C., Huang, X., Yang, J., Kyoda, T., Leyva, R., Banares, S., and Hu, Y. (2011). Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024341"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","article-title":"BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis","volume":"8","author":"Cheng","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1101\/gad.897601","article-title":"BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak","volume":"15","author":"Zong","year":"2001","journal-title":"Genes Dev."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Zamorano, S., Rojas-Rivera, D., Lisbona, F., Parra, V., Court, F.A., Villegas, R., Cheng, E.H., Korsmeyer, S.J., Lavandero, S., and Hetz, C. (2012). A BAX\/BAK and cyclophilin D-independent intrinsic apoptosis pathway. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037782"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1038\/cddis.2013.297","article-title":"Multiple mechanisms repress N-Bak mRNA translation in the healthy and apoptotic neurons","volume":"4","author":"Jakobson","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.3780-15.2016","article-title":"Bok is not pro-apoptotic but suppresses poly ADP-ribose polymerase-dependent cell death pathways and protects against excitotoxic and seizure-induced neuronal injury","volume":"36","author":"Engel","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1523\/JNEUROSCI.2453-14.2015","article-title":"Bax regulates neuronal Ca2+ Homeostasis","volume":"35","author":"Kilbride","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1523\/JNEUROSCI.2315-06.2006","article-title":"Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS","volume":"26","author":"Gould","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.cdd.4402089","article-title":"Endoplasmic reticulum stress-induced apoptosis requires bax for commitment and Apaf-1 for execution in primary neurons","volume":"14","author":"Smith","year":"2007","journal-title":"Cell Death Differ."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/neu.2007.0441","article-title":"Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury","volume":"25","author":"Tehranian","year":"2008","journal-title":"J. Neurotrauma"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1128\/MCB.25.19.8732-8747.2005","article-title":"Mutually Exclusive Subsets of BH3-Only Proteins Are Activated by the p53 and c-Jun N-Terminal Kinase\/c-Jun Signaling Pathways during Cortical Neuron Apoptosis Induced by Arsenite","volume":"25","author":"Wong","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1471-4159.2005.03676.x","article-title":"The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons","volume":"96","author":"Wyttenbach","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2016.02.026","article-title":"BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation","volume":"165","author":"Llambi","year":"2016","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"14782","DOI":"10.1073\/pnas.1417253111","article-title":"Activation of mitochondrial protease OMA1 by bax and bak promotes cytochrome c release during apoptosis","volume":"111","author":"Jiang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1083\/jcb.201507022","article-title":"Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria","volume":"212","author":"Korwitz","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","article-title":"Autophagy and apoptosis dysfunction in neurodegenerative disorders","volume":"112","author":"Ghavami","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Reichert, C.O., de Freitas, F.A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P.d.L., Levy, D., and Bydlowski, S.P. (2020). Ferroptosis mechanisms involved in neurodegenerative diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228765"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: Molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.21037\/atm-21-4863","article-title":"A narrative review of mechanisms of ferroptosis in cancer: New challenges and opportunities","volume":"9","author":"Jiang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2147\/JIR.S351799","article-title":"Ferroptosis and Its Potential Role in the Nervous System Diseases","volume":"15","author":"Zhou","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_97","first-page":"235","article-title":"Iron Dyshomeostasis and Ferroptosis: A New Alzheimer\u2019s Disease Hypothesis?","volume":"14","author":"Wang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-022-02570-3","article-title":"Ferroptosis is involved in regulating perioperative neurocognitive disorders: Emerging perspectives","volume":"19","author":"Song","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/nu4101399","article-title":"Dysregulation of glutathione homeostasis in neurodegenerative diseases","volume":"4","author":"Johnson","year":"2012","journal-title":"Nutrients"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"105580","DOI":"10.1016\/j.phrs.2021.105580","article-title":"Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy","volume":"168","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jnc.15002","article-title":"Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases","volume":"154","author":"Corti","year":"2020","journal-title":"J. Neurochem."},{"key":"ref_103","first-page":"165","article-title":"Cell death: Apoptosis versus necrosis (review)","volume":"21","author":"Kanduc","year":"2002","journal-title":"Int. J. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/BJ20081118","article-title":"Mechanisms of neuronal death in disease: Defining the models and the players","volume":"415","author":"Ribe","year":"2008","journal-title":"Biochem. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/bc.bc_27_16","article-title":"Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration","volume":"3","author":"Glushakova","year":"2017","journal-title":"Brain Circ."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn809","article-title":"Neural stem cell therapy for neurological diseases: Dreams and reality","volume":"3","author":"Rossi","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s004060170035","article-title":"Adult neurogenesis: A compensatory mechanism for neuronal damage","volume":"251","author":"Kuhn","year":"2001","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1073858412447875","article-title":"Caspase inhibitors: Prospective therapies for stroke","volume":"19","author":"Akpan","year":"2013","journal-title":"Neuroscientist"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/cdd.2009.180","article-title":"Neuronal caspase-3 signaling: Not only cell death","volume":"17","author":"Cavallucci","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-385504-6.00007-5","article-title":"Regulation of caspases in the nervous system: Implications for functions in health and disease","volume":"99","author":"Troy","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mrdd.1036","article-title":"Apoptosis and brain development","volume":"7","author":"Roth","year":"2001","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1469-7580.2010.01226.x","article-title":"Imaging selective vulnerability in the developing nervous system","volume":"217","author":"Ferriero","year":"2010","journal-title":"J. Anat."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1523\/JNEUROSCI.21-01-00169.2001","article-title":"Bcl-XL-caspase-9 interactions in the developing nervous system: Evidence for multiple death pathways","volume":"21","author":"Zaidi","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1002\/wrna.1463","article-title":"Noncoding RNAs in Alzheimer\u2019s disease","volume":"9","author":"Idda","year":"2018","journal-title":"WIREs RNA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-019-1608-z","article-title":"The link between chronic pain and Alzheimer\u2019s disease","volume":"16","author":"Cao","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s40478-019-0848-6","article-title":"Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer\u2019s disease and not in other tauopathies","volume":"7","author":"Pires","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"153331752199614","DOI":"10.1177\/1533317521996147","article-title":"Therapeutic Potential of Neu1 in Alzheimer\u2019s Disease Via the Immune System","volume":"36","author":"Khan","year":"2021","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jalz.2018.06.3056","article-title":"Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer\u2019s disease","volume":"14","author":"Nicolas","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e226664","DOI":"10.1136\/bcr-2018-226664","article-title":"Difficult case of a rare form of familial Alzheimer\u2019s disease with PSEN1 P117L mutation","volume":"11","author":"Rocha","year":"2018","journal-title":"BMJ Case Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000485899","article-title":"Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1","volume":"18","author":"Tiedt","year":"2018","journal-title":"Neurodegener. Dis."},{"key":"ref_123","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e00699","DOI":"10.1002\/prp2.699","article-title":"Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2\/XIAP\/PARP signaling after coronary microembolization in rats","volume":"9","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11064-014-1454-4","article-title":"Apoptosis in Alzheimer\u2019s Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues","volume":"39","author":"Obulesu","year":"2014","journal-title":"Neurochem. Res."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Kim, B.G., Kwon, H.Y., Sohn, E.J., Hwang, S., Kwon, O.S., and Kim, S.-H. (2014). Activation of caspases and inhibition of ribosome biogenesis mediate antitumor activity of Chijongdan in A549 non-small lung cancer cells. BMC Complement. Altern. Med., 14.","DOI":"10.1186\/1472-6882-14-420"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"107839","DOI":"10.1016\/j.celrep.2020.107839","article-title":"Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid \u03b2-Protein-Induced Synapse Loss in Alzheimer\u2019s Disease","volume":"31","author":"Park","year":"2020","journal-title":"Cell Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2017.08.007","article-title":"APP\/A\u03b2 structural diversity and Alzheimer\u2019s disease pathogenesis","volume":"110","author":"Roher","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/10715762.2013.857018","article-title":"Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in A\u03b2(1-42)-induced rat model of Alzheimer\u2019s disease","volume":"48","author":"Uyanikgil","year":"2014","journal-title":"Free Radic. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12038-017-9698-1","article-title":"miR-200a-3p promotes \u03b2-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer\u2019s disease","volume":"42","author":"Zhang","year":"2017","journal-title":"J. Biosci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: Structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2018.12.005","article-title":"It\u2019s all about tau","volume":"175","author":"Deaton","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Jurcau, A. (2021). The role of natural antioxidants in the prevention of dementia\u2014Where do we stand and future perspectives. Nutrients, 13.","DOI":"10.3390\/nu13020282"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jcmm.12008","article-title":"Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer\u2019s disease","volume":"17","author":"Honarnejad","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"18269","DOI":"10.1074\/jbc.M115.640177","article-title":"Cellular FLICE-like inhibitory protein (c-FLIP) and PS1-associated protein (PSAP) mediate presenilin 1-induced \u03b3-secretase-dependent and -independent apoptosis, respectively","volume":"290","author":"Zeng","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbadis.2011.10.003","article-title":"Elevation of glutathione as a therapeutic strategy in Alzheimer disease","volume":"1822","author":"Pocernich","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1567205012666150302160308","article-title":"Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer\u2019s Disease","volume":"12","author":"Braidy","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","article-title":"Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease","volume":"6","author":"Neddens","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1582-4934.2011.01507.x","article-title":"Interaction between pathogenic proteins in neurodegenerative disorders","volume":"16","author":"Jellinger","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"ref_141","first-page":"1720621","article-title":"Alpha-Synuclein in Parkinson\u2019s Disease: From Pathogenetic Dysfunction to Potential Clinical Application","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinsons Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s Disease with the Alpha-Synuclein Protein","volume":"11","author":"Granado","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp-2013-305114","article-title":"Cognitive decline in prodromal Huntington disease: Implications for clinical trials","volume":"84","author":"Paulsen","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","article-title":"The neuropathology, pathophysiology and genetics of multiple system atrophy","volume":"38","author":"Ahmed","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","article-title":"Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants","volume":"33","author":"Saberi","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/intbio\/zyz017","article-title":"Studying Parkinson\u2019s disease using Caenorhabditis elegans models in microfluidic devices","volume":"11","author":"Youssef","year":"2019","journal-title":"Integr. Biol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/jnc.14902","article-title":"Are genetic and idiopathic forms of Parkinson\u2019s disease the same disease?","volume":"152","author":"Mestre","year":"2020","journal-title":"J. Neurochem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnins.2018.00693","article-title":"Emerging Treatment Approaches for Parkinson\u2019s Disease","volume":"12","author":"Stoker","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-201981","article-title":"Mitochondria and Parkinson\u2019s disease: Clinical, molecular, and translational aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00441-017-2768-8","article-title":"The genetic architecture of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"373","author":"Larsen","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Sharma","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","article-title":"Aggregated \u03b1-synuclein and complex I deficiency: Exploration of their relationship in differentiated neurons","volume":"6","author":"Reeve","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijbiomac.2020.10.196","article-title":"Transient transfection of WT-\u03b1S and A53T-\u03b1S brought about a mild apoptosis due to degradation of released cytochrome c through PARC","volume":"166","author":"Salehi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson\u2019s disease","volume":"589","author":"Haddad","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2019.08.041","article-title":"Silencing of TRIM10 alleviates apoptosis in cellular model of Parkinson\u2019s disease","volume":"518","author":"Huang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_161","first-page":"615","article-title":"Mitochondria-mediated damage to dopaminergic neurons in Parkinson\u2019s disease (Review)","volume":"41","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/BJ20131519","article-title":"The neurotoxicity of 5-S-cysteinyldopamine is mediated by the early activation of ERK1\/2 followed by the subsequent activation of ASK1\/JNK1\/2 pro-apoptotic signaling","volume":"463","author":"Vauzour","year":"2014","journal-title":"Biochem. J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"453","DOI":"10.12659\/MSM.911166","article-title":"Chlorogenic acid exerts beneficial effects in 6-hydroxydopamine-induced neurotoxicity by inhibition of endoplasmic reticulum stress","volume":"25","author":"Shan","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"a009365","DOI":"10.1101\/cshperspect.a009365","article-title":"Programmed cell death in Parkinson\u2019s disease","volume":"2","author":"Venderova","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Wu, C.-R., Chang, H.-C., Cheng, Y.-D., Lan, W.-C., Yang, S.-E., and Ching, H. (2018). Aqueous Extract of Davallia mariesii Attenuates 6-Hydroxydopamine-Induced Oxidative Damage and Apoptosis in B35 Cells Through Inhibition of Caspase Cascade and Activation of PI3K\/AKT\/GSK-3\u03b2 Pathway. Nutrients, 10.","DOI":"10.3390\/nu10101449"},{"key":"ref_166","unstructured":"Konnova, E.A., and Swanberg, M. (2018). Animal Models of Parkinson\u2019s Disease. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects, Codon Publications."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"174202","DOI":"10.1016\/j.ejphar.2021.174202","article-title":"Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK\/GSK-3\u03b2\/PP2A pathway in Parkinson\u2019s disease","volume":"907","author":"Su","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ajmg.a.38494","article-title":"Therapy development in Huntington disease: From current strategies to emerging opportunities","volume":"176","author":"Dickey","year":"2018","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"Huntington disease: A quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1134\/S0026893319060037","article-title":"The Role of Mutant RNA in the Pathogenesis of Huntington\u2019s Disease and Other Polyglutamine Diseases","volume":"53","author":"Bogomazova","year":"2019","journal-title":"Mol. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington\u2019s Disease Mouse Model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1096\/fj.201902277RR","article-title":"Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction","volume":"34","author":"Ghosh","year":"2020","journal-title":"FASEB J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mito.2020.08.003","article-title":"Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease","volume":"55","author":"Pantiya","year":"2020","journal-title":"Mitochondrion"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"104637","DOI":"10.1016\/j.nbd.2019.104637","article-title":"Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140\/Q140 mouse model of Huntington\u2019s disease","volume":"134","author":"McAdam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.7150\/ijbs.9898","article-title":"Preclinical and clinical investigations of mood stabilizers for Huntington\u2019s disease: What have we learned?","volume":"10","author":"Scheuing","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","article-title":"Apoptosis in Huntington\u2019s disease","volume":"27","author":"Hickey","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1111\/j.1742-4658.2008.06563.x","article-title":"Huntington\u2019s disease: Roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription","volume":"275","author":"Bhattacharyya","year":"2008","journal-title":"FEBS J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12640-017-9766-1","article-title":"Huntington\u2019s Disease and Mitochondria","volume":"32","author":"Ghaedi","year":"2017","journal-title":"Neurotox. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/JHD-2012-120018","article-title":"New perspectives on the neuropathology in Huntington\u2019s disease in the human brain and its relation to symptom variation","volume":"1","author":"Waldvogel","year":"2012","journal-title":"J. Huntingtons. Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"581907","DOI":"10.3389\/fncel.2020.581907","article-title":"Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises","volume":"14","author":"McAlary","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77716-5","article-title":"Premature termination codons in SOD1 causing Amyotrophic Lateral Sclerosis are predicted to escape the nonsense-mediated mRNA decay","volume":"10","author":"Guissart","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Rosa, A.C., Corsi, D., Cavi, N., Bruni, N., and Dosio, F. (2021). Superoxide dismutase administration: A review of proposed human uses. Molecules, 26.","DOI":"10.3390\/molecules26071844"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(05)70142-3","article-title":"Apoptosis in amyotrophic lateral sclerosis\u2014What is the evidence?","volume":"4","author":"Sathasivam","year":"2005","journal-title":"Lancet Neurol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"22406","DOI":"10.1074\/jbc.M702793200","article-title":"N-terminal cleavage of GSK-3 by calpain: A new form of GSK-3 regulation","volume":"282","author":"Lucas","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2174\/138955709788922647","article-title":"GSK3 Inhibitors and Disease","volume":"9","author":"Hernandez","year":"2009","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-2008-15204","article-title":"GSK-3 inhibitors: A ray of hope for the treatment of Alzheimer\u2019s disease?","volume":"15","author":"Martinez","year":"2008","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjp.0707471","article-title":"Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation","volume":"152","author":"Selenica","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1755-5949.2009.00086.x","article-title":"Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium","volume":"15","author":"Camins","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-4159.2004.02422.x","article-title":"Glycogen synthase kinase 3: A drug target for CNS therapies","volume":"89","author":"Bhat","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_193","first-page":"962","article-title":"Regulation of GSK-3\u03b2 by calpain in the 3-nitropropionic acid model","volume":"20","author":"Camins","year":"2009","journal-title":"Hippocampus"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3233\/JAD-2009-1004","article-title":"Increase of bdnf serum concentration in lithium treated patients with early alzheimer\u2019s disease","volume":"16","author":"Leyhe","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimer\u2019s disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002826-200301000-00005","article-title":"Minocycline and Other Tetracycline Derivatives: A Neuroprotective Strategy in Parkinson\u2019s Disease and Huntington\u2019s Disease","volume":"26","author":"Thomas","year":"2003","journal-title":"Clin. Neuropharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fncel.2019.00103","article-title":"Mitochondrial dysfunction in huntington\u2019s disease; interplay between HSF1, p53 and PGC-1\u03b1 transcription factors","volume":"13","author":"Intihar","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Wang, F., Fu, X., Chen, X., Chen, X., and Zhao, Y. (2010). Mitochondrial Uncoupling Inhibits p53 Mitochondrial Translocation in TPA-Challenged Skin Epidermal JB6 Cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013459"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ana.10489","article-title":"Apoptosis in Parkinson\u2019s disease: Signals for neuronal degradation","volume":"53","author":"Tatton","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0006-8993(00)03293-5","article-title":"CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: A possible role for ERK activation","volume":"893","author":"Pulliam","year":"2001","journal-title":"Brain Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00702-002-0827-z","article-title":"Neuroprotection by deprenyl and other propargylamines: Glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B","volume":"110","author":"Tatton","year":"2003","journal-title":"J. Neural Transm."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/jpet.301.2.753","article-title":"Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells","volume":"301","author":"Tatton","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_205","first-page":"2","article-title":"Reduced Apoptosis after Nerve Growth Factor and Serum Withdrawal: Conversion of Tetrameric Glyceraldehyde-3-Phosphate Dehydrogenase to a Dimer","volume":"57","author":"Carlile","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0278-5846(03)00025-3","article-title":"Prospects for antiapoptotic drug therapy of neurodegenerative diseases","volume":"27","author":"Waldmeier","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.pharmtox.44.101802.121840","article-title":"Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration","volume":"44","author":"Wang","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-079X.2006.00377.x","article-title":"Reduced oxidative damage in ALS by high-dose enteral melatonin treatment","volume":"41","author":"Weishaupt","year":"2006","journal-title":"J. Pineal Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-006-9353-x","article-title":"Anti-inflammatory effect of melatonin on A\u03b2 vaccination in mice","volume":"298","author":"Jesudason","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-079X.2008.00570.x","article-title":"Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-\u03b21\u201342","volume":"45","author":"Zhou","year":"2008","journal-title":"J. Pineal Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2005.08.014","article-title":"Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer\u2019s disease","volume":"40","author":"Feng","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2005.01.003","article-title":"Melatonin attenuates amyloid beta25\u201335-induced apoptosis in mouse microglial BV2 cells","volume":"380","author":"Jang","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-079X.2011.00864.x","article-title":"Melatonin treatment restores mitochondrial function in Alzheimer\u2019s mice: A mitochondrial protective role of melatonin membrane receptor signaling","volume":"51","author":"Dragicevic","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1745-7254.2005.00102.x","article-title":"Effects of melatonin on wortmannin-induced tau hyperphosphorylation","volume":"26","author":"Deng","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0076-6879(05)96024-2","article-title":"Peroxynitrite in the pathogenesis of Parkinson\u2019s disease and the neuroprotective role of metallothioneins","volume":"396","author":"Ebadi","year":"2005","journal-title":"Methods Enzymol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-079X.2007.00449.x","article-title":"Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells","volume":"43","author":"Chetsawang","year":"2007","journal-title":"J. Pineal Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-079X.2005.00308.x","article-title":"Inhibition of the cdk5\/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson\u2019s disease","volume":"40","author":"Alvira","year":"2006","journal-title":"J. Pineal Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-079X.2004.00140.x","article-title":"Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes","volume":"37","author":"Jou","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2004.08.068","article-title":"The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells","volume":"371","author":"Chetsawang","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","article-title":"Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington\u2019s disease","volume":"37","author":"Montilla","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1523\/JNEUROSCI.1867-08.2008","article-title":"Inhibitors of cytochrome c release with therapeutic potential for Huntington\u2019s disease","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1074\/jbc.C100044200","article-title":"Huntingtin\u2019s Neuroprotective Activity Occurs via Inhibition of Procaspase-9 Processing","volume":"276","author":"Rigamonti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1755-5949.2009.00105.x","article-title":"The antiapoptotic activity of melatonin in neurodegenerative diseases","volume":"15","author":"Wang","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/JMN:28:2:125","article-title":"Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons","volume":"28","author":"Kooncumchoo","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q 10 in early Parkinson disease: Evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/01.WNL.0000096376.03678.C1","article-title":"Idebenone treatment fails to slow cognitive decline in Alzheimer\u2019s disease","volume":"61","author":"Thal","year":"2003","journal-title":"Neurology"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: The in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/156720209787466019","article-title":"Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection","volume":"6","author":"Pallas","year":"2009","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1753-4887.2008.00109.x","article-title":"Resveratrol and novel potent activators of SIRT1: Effects on aging and age-related diseases","volume":"66","author":"Knutson","year":"2008","journal-title":"Nutr. Rev."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2174\/092986708785132951","article-title":"Trans-Resveratrol: A Magical Elixir of Eternal Youth?","volume":"15","author":"Orallo","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.neuroscience.2007.04.029","article-title":"Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons","volume":"147","author":"Alvira","year":"2007","journal-title":"Neuroscience"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Juki\u0107, I., Kolobari\u0107, N., Stupin, A., Mati\u0107, A., Kozina, N., Mihaljevi\u0107, Z., Mihalj, M., \u0160u\u0161njara, P., Stupin, M., and \u0106uri\u0107, \u017d.B. (2021). Carnosine, small but mighty\u2014Prospect of use as functional ingredient for functional food formulation. Antioxidants, 10.","DOI":"10.3390\/antiox10071037"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3892\/etm.2017.4571","article-title":"Neuroprotective effect of carnosine against salsolinol-induced Parkinson\u2019s disease","volume":"14","author":"Zhao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/rej.2008.0716","article-title":"Carnisone increases efficiency of DOPA therapy of Parkinson\u2019s disease: A pilot study","volume":"11","author":"Boldyrev","year":"2008","journal-title":"Rejuvenation Res."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/ern.09.32","article-title":"Carnosine, diabetes and Alzheimer\u2019s disease","volume":"9","author":"Hipkiss","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Hajialyani, M., Farzaei, M.H., Echeverr\u00eda, J., Nabavi, S.M., Uriarte, E., and Eduardo, S.S. (2019). Hesperidin as a neuroprotective agent: A review of animal and clinical evidence. Molecules, 24.","DOI":"10.3390\/molecules24030648"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF02968255","article-title":"Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin","volume":"29","author":"Cho","year":"2006","journal-title":"Arch. Pharm. Res."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/13880209.2016.1231695","article-title":"Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats","volume":"55","author":"Diwan","year":"2017","journal-title":"Pharm. Biol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/ADR-200171","article-title":"Alzheimer\u2019s Disease, Inflammation, and the Role of Antioxidants","volume":"4","author":"Sinyor","year":"2020","journal-title":"J. Alzheimer\u2019s Dis. Reports"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"200084","DOI":"10.1098\/rsob.200084","article-title":"Role of antioxidants and a nutrient rich diet in Alzheimer\u2019s disease","volume":"10","author":"Veurink","year":"2020","journal-title":"Open Biol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1074\/jbc.M109641200","article-title":"Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant: Implication for inflammation-associated carcinogenesis","volume":"277","author":"Nakamura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Santi, C., Scimmi, C., and Sancineto, L. (2021). Ebselen and analogues: Pharmacological properties and synthetic strategies for their preparation. Molecules, 26.","DOI":"10.3390\/molecules26144230"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jpsychires.2018.11.021","article-title":"A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer\u2019s disease","volume":"109","author":"Martini","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.10350","article-title":"p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism","volume":"52","author":"Duan","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1073\/pnas.062059899","article-title":"Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons","volume":"99","author":"Paitel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(02)00818-8","article-title":"p53: Good cop\/bad cop","volume":"110","author":"Sharpless","year":"2002","journal-title":"Cell"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0027-5107(01)00273-1","article-title":"Pifithrin-\u03b1, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro","volume":"499","author":"Bassi","year":"2002","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(01)00902-5","article-title":"Release and aggregation of cytochrome c and \u03b1-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole","volume":"417","author":"Kakimura","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0039-6257(03)00004-3","article-title":"Role of alpha-2 agonists in neuroprotection","volume":"48","author":"Wheeler","year":"2003","journal-title":"Surv. Ophthalmol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0306-4522(02)00940-5","article-title":"Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons","volume":"118","author":"MacLusky","year":"2003","journal-title":"Neuroscience"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.WNL.0000044047.58984.2F","article-title":"Slowing Parkinson\u2019s disease progression: Recent dopamine agonist trials","volume":"60","author":"Ahlskog","year":"2003","journal-title":"Neurology"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/13543784.13.11.1469","article-title":"The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer\u2019s disease","volume":"13","author":"Imbimbo","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.neuropharm.2005.07.004","article-title":"Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer\u2019s \u03b2-amyloid fibrils in vitro","volume":"49","author":"Hirohata","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.brainresrev.2004.12.024","article-title":"New insights into COX-2 biology and inhibition","volume":"48","author":"Patrignani","year":"2005","journal-title":"Brain Res. Rev."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0269881108097630","article-title":"Ibuprofen modifies cognitive disease progression in an Alzheimer\u2019s mouse model","volume":"24","author":"Coen","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF03325217","article-title":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer\u2019s disease","volume":"21","author":"Pasqualetti","year":"2009","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WAD.0b013e31815d1048","article-title":"Safety, Tolerability, Pharmacokinetics, and A\u03b2 Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals","volume":"21","author":"Galasko","year":"2007","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1568007054038201","article-title":"The Role of COX-1 and COX-2 in Alzheimers Disease Pathology and the Therapeutic Potentials of Non-Steroidal Anti-Inflammatory Drugs","volume":"4","author":"Hoozemans","year":"2005","journal-title":"Curr. Drug Target-CNS Neurol. Disord."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory Agents: Present and Future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0039-6257(03)00005-5","article-title":"Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer\u2019s disease: Anti-apoptosis by alpha-2-adrenergic receptor activation","volume":"48","author":"Tatton","year":"2003","journal-title":"Surv. Ophthalmol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1359-6446(03)03000-9","article-title":"Interrupting apoptosis in neurodegenerative disease: Potential for effective therapy?","volume":"9","author":"Waldmeier","year":"2004","journal-title":"Drug Discov. Today"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3892\/mmr.2017.6350","article-title":"Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury","volume":"15","author":"Huang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_265","first-page":"36","article-title":"Ascomycin and FK506: Pharmacology and Therapeutic Potential as Anticonvulsants and Neuroprotectants","volume":"14","year":"2008","journal-title":"CNS Drug Rev."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3940(96)12384-3","article-title":"FK506, a Ca2+\/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus","volume":"205","author":"Lu","year":"1996","journal-title":"Neurosci. Lett."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-5728(94)90049-3","article-title":"Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL\/6 mice","volume":"50","author":"Kitamura","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/exnr.2000.7405","article-title":"FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons","volume":"164","author":"Castilho","year":"2000","journal-title":"Exp. Neurol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2010.03.009","article-title":"Neuroprotective effects of FK506 against excitotoxicity in organotypic hippocampal slice culture","volume":"474","author":"Lee","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.brainresbull.2006.03.013","article-title":"Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington\u2019s disease mutation","volume":"69","year":"2006","journal-title":"Brain Res. Bull."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1471-4159.2008.05252.x","article-title":"Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells","volume":"105","author":"Alberch","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1523\/JNEUROSCI.3706-05.2006","article-title":"Inhibition of calcineurin by FK506 protects against polyglutamine- huntingtin toxicity through an increase of huntingtin phosphorylation at S421","volume":"26","author":"Pardo","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-6606-2-33","article-title":"Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington\u2019s disease","volume":"2","author":"Pineda","year":"2009","journal-title":"Mol. Brain"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neures.2009.01.005","article-title":"Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: Possible role of nitric oxide","volume":"63","author":"Kumar","year":"2009","journal-title":"Neurosci. Res."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuint.2009.04.012","article-title":"Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture","volume":"55","author":"Chan","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1124\/jpet.103.057497","article-title":"Inhibition of Cell Cycle Pathway by Flavopiridol Promotes Survival of Cerebellar Granule Cells after an Excitotoxic Treatment","volume":"308","author":"Verdaguer","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.cdd.4401575","article-title":"Novel link between E2F and p53: Proapoptotic cofactors of p53 are transcriptionally upregulated by E2F","volume":"12","author":"Hershko","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2002-4315","article-title":"Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer\u2019s disease","volume":"4","author":"Herrup","year":"2002","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dnarep.2004.03.034","article-title":"The emerging role of E2F-1 in the DNA damage response and checkpoint control","volume":"3","author":"Stevens","year":"2004","journal-title":"DNA Repair"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1523\/JNEUROSCI.1570-05.2005","article-title":"Bim is a direct target of a neuronal E2F-dependent apoptotic pathway","volume":"25","author":"Biswas","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1074\/jbc.M312866200","article-title":"Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis","volume":"279","author":"Hershko","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12031-009-9238-z","article-title":"Cholinergic involvement in alzheimer\u2019s disease. A link with NGF maturation and degradation","volume":"40","author":"Cuello","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.expneurol.2008.03.004","article-title":"Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons","volume":"211","author":"Bishop","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","article-title":"Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta","volume":"25","author":"Baquet","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fnhum.2022.924155","article-title":"The Role of Brain-Derived Neurotrophic Factor Signaling in Central Nervous System Disease Pathogenesis","volume":"16","author":"Dou","year":"2022","journal-title":"Front. Hum. Neurosci."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI41356","article-title":"Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents","volume":"120","author":"Massa","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of huntington\u2019s disease","volume":"33","author":"Simmons","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JHD-170275","article-title":"Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington\u2019s Disease","volume":"6","author":"Simmons","year":"2017","journal-title":"J. Huntingtons Dis."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0119-y","article-title":"Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: Emerging therapeutic modality for Alzheimer\u2019s disease","volume":"11","author":"Kazim","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.arr.2008.01.001","article-title":"Molecular mechanism of PPAR in the regulation of age-related inflammation","volume":"7","author":"Chung","year":"2008","journal-title":"Ageing Res. Rev."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnagi.2010.00021","article-title":"The nuclear receptor PPAR\u03b3 as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer\u2019s disease","volume":"2","author":"Nicolakakis","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate alzheimer\u2019s disease: Results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jdi.12246","article-title":"Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis","volume":"6","author":"Lu","year":"2015","journal-title":"J. Diabetes Investig."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: Mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"Gandor","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease","volume":"115","author":"Pol","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neurobiolaging.2007.09.012","article-title":"Serum total cholesterol, statins and cognition in non-demented elderly","volume":"30","author":"Solomon","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"11226","DOI":"10.1523\/JNEUROSCI.6150-08.2009","article-title":"Statin\u2019s excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via Rho-ROCK signaling","volume":"29","author":"Ma","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-2009-1052","article-title":"Pretreatment with lovastatin prevents n-methyl-d-aspartate-induced neurodegeneration in the magnocellular nucleus basalis and behavioral dysfunction","volume":"17","author":"Dolga","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/STROKEAHA.107.498923","article-title":"Simvastatin reduces the association of NMDA receptors to lipid rafts: A cholesterol-mediated effect in neuroprotection","volume":"39","author":"Ponce","year":"2008","journal-title":"Stroke"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"e12108","DOI":"10.1002\/trc2.12108","article-title":"Statin therapy and risk of Alzheimer\u2019s and age-related neurodegenerative diseases","volume":"6","author":"Branigan","year":"2020","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Protect Cortical Neurons from Excitotoxicity","volume":"23","author":"Zacco","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2009.11.015","article-title":"Lovastatin ameliorates \u03b1-synuclein accumulation and oxidation in transgenic mouse models of \u03b1-synucleinopathies","volume":"221","author":"Koob","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2796.2009.02173.x","article-title":"Statins and amyotrophic lateral sclerosis\u2014The level of evidence for an association","volume":"266","author":"Lash","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1755-5949.2010.00179.x","article-title":"The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: Enthusiasm lost too soon?","volume":"16","author":"Sellner","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1474-4422(11)70153-3","article-title":"Combining statins with interferon beta in multiple sclerosis: Think twice, it might not be all right","volume":"10","author":"Zamvil","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Paul, F., Waiczies, S., Wuerfel, J., Bellmann-Strobl, J., D\u00f6rr, J., Waiczies, H., Haertle, M., Wernecke, K.D., Volk, H.-D., and Aktas, O. (2008). Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001928"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jrr\/rrt048","article-title":"Vitamin E: Tocopherols and tocotrienols as potential radiation countermeasures","volume":"54","author":"Singh","year":"2013","journal-title":"J. Radiat. Res."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","article-title":"Ferroptosis Inhibition: Mechanisms and Opportunities","volume":"38","author":"Angeli","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Hinman, A., Holst, C.R., Latham, J.C., Bruegger, J.J., Ulas, G., McCusker, K.P., Amagata, A., Davis, D., Hoff, K.G., and Kahn-Kirby, A.H. (2018). Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201369"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.chembiol.2020.03.012","article-title":"Selenium: Tracing Another Essential Element of Ferroptotic Cell Death","volume":"27","author":"Conrad","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53154-w","article-title":"Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafish","volume":"9","author":"Faria","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_319","first-page":"1","article-title":"Evaluation of the Neuroprotective Potential of N-Acetylcysteine for Prevention and Treatment of Cognitive Aging and Dementia","volume":"4","author":"Hara","year":"2017","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2006.06.042","article-title":"Protective effect of N-acetyl-l-cysteine on amyloid \u03b2-peptide-induced learning and memory deficits in mice","volume":"1109","author":"Fu","year":"2006","journal-title":"Brain Res."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ana.25356","article-title":"N-Acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice","volume":"84","author":"Karuppagounder","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1358\/mf.2008.30.1.1090962","article-title":"Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approaches","volume":"30","author":"Camins","year":"2008","journal-title":"Methods Find. Exp. Clin. Pharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/21\/7207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:02:02Z","timestamp":1760144522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/21\/7207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":322,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["molecules27217207"],"URL":"https:\/\/doi.org\/10.3390\/molecules27217207","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}